TrialCirculation. Cardiovascular quality and outcomes2013

Frequency, predictors, and consequences of crossing over to revascularization within 12 months of randomization to optimal medical therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial.

John A Spertus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.